 | • レポートコード：20QY06-03005 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ヒト凝固第VIII因子のグローバル市場について種類別（組換え第VIII因子、血漿由来第VIII因子）、用途別（血友病A、自発性/外傷、外科、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ヒト凝固第VIII因子市場の概要 ・世界の主要地域別ヒト凝固第VIII因子市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヒト凝固第VIII因子市場規模2015-2026：種類別（組換え第VIII因子、血漿由来第VIII因子） ・世界のヒト凝固第VIII因子市場規模2015-2026：用途別（血友病A、自発性/外傷、外科、その他） ・ヒト凝固第VIII因子の北米市場規模2015-2020 ・ヒト凝固第VIII因子のヨーロッパ市場規模2015-2020 ・ヒト凝固第VIII因子の中国市場規模2015-2020 ・ヒト凝固第VIII因子の日本市場規模2015-2020 ・ヒト凝固第VIII因子の東南アジア市場規模2015-2020 ・ヒト凝固第VIII因子のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Shire (Baxter)、Bayer、CSL、Pfizer、Grifols、Biogen、Octapharma、NovoNordisk、Greencross、Kedrion、BPL、Hualan Bio、RAAS） ・ヒト凝固第VIII因子の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒト凝固第VIII因子の市場動向・機会・課題 ・調査の結論 |
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A.
North America is the largest consumption market of Human Coagulation Factor VIII, with sales market share nearly 46%. And the production market share of Human Coagulation Factor VIII is 58%. The manufacturers of Human Coagulation Factor VIII in North America have big and medium scale.
The second place is Europe, following North America with the sales market share of 36% and the production market share over 28%. Many European players have plants in USA due to rich plasma source. So there are a large number of Human Coagulation Factor VIIIs for import from other regions.
Asia is another important market of Human Coagulation Factor VIII, enjoying 10% production market share and 11% sales market share. Especially in China, the sales and price of Factor VIII are controlled by country, and the price in China is different from other regions.
Main players are from USA and Europe, like Baxter, Bayer, and they have many plants in other regions. China also can supply Human Coagulation Factor VIII, but the products are mainly consumed in China.
Market competition is intense. Baxter, Bayer, CSL, Pfizer, Grifols, etc. are the leaders of the industry, and hold key technologies, with high-end customers, have been formed in the monopoly position in the industry. However, with further expanding market, there will be more manufactures in the future.
Market Analysis and Insights: Global Human Coagulation Factor VIII Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Coagulation Factor VIII market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Human Coagulation Factor VIII industry.
Based on our recent survey, we have several different scenarios about the Human Coagulation Factor VIII YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 7911 million in 2019. The market size of Human Coagulation Factor VIII will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Human Coagulation Factor VIII Scope and Market Size
The global Human Coagulation Factor VIII market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Coagulation Factor VIII market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Human Coagulation Factor VIII market is segmented into
Recombinant Factor VIII
Plasma-derived Factor VIII
Segment by Application, the Human Coagulation Factor VIII market is segmented into
Hemophilia A
Spontanous / Trauma
Surgical
Other
The Human Coagulation Factor VIII market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Coagulation Factor VIII market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Coagulation Factor VIII Market Share Analysis
Human Coagulation Factor VIII market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Coagulation Factor VIII business, the date to enter into the Human Coagulation Factor VIII market, Human Coagulation Factor VIII product introduction, recent developments, etc.
The major vendors covered:
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
1 Human Coagulation Factor VIII Market Overview
1.1 Human Coagulation Factor VIII Product Scope
1.2 Human Coagulation Factor VIII Segment by Type
1.2.1 Global Human Coagulation Factor VIII Sales by Type (2020-2026)
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Human Coagulation Factor VIII Segment by Application
1.3.1 Global Human Coagulation Factor VIII Sales Comparison by Application (2020-2026)
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Human Coagulation Factor VIII Market Estimates and Forecasts (2015-2026)
1.4.1 Global Human Coagulation Factor VIII Sales Growth Rate (2015-2026)
1.4.2 Global Human Coagulation Factor VIII Revenue and Growth Rate (2015-2026)
1.4.3 Global Human Coagulation Factor VIII Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Human Coagulation Factor VIII Industry Impact
1.5.1 How the Covid-19 is Affecting the Human Coagulation Factor VIII Industry
1.5.1.1 Human Coagulation Factor VIII Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Human Coagulation Factor VIII Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Human Coagulation Factor VIII Players to Combat Covid-19 Impact
2 Human Coagulation Factor VIII Estimate and Forecast by Region
2.1 Global Human Coagulation Factor VIII Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Human Coagulation Factor VIII Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Human Coagulation Factor VIII Sales Market Share by Region (2015-2020)
2.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Region (2015-2020)
2.3 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Human Coagulation Factor VIII Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Human Coagulation Factor VIII Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Human Coagulation Factor VIII Estimates and Projections (2015-2026)
2.4.2 Europe Human Coagulation Factor VIII Estimates and Projections (2015-2026)
2.4.3 China Human Coagulation Factor VIII Estimates and Projections (2015-2026)
2.4.4 Japan Human Coagulation Factor VIII Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Human Coagulation Factor VIII Estimates and Projections (2015-2026)
2.4.6 India Human Coagulation Factor VIII Estimates and Projections (2015-2026)
3 Global Human Coagulation Factor VIII Competition Landscape by Players
3.1 Global Top Human Coagulation Factor VIII Players by Sales (2015-2020)
3.2 Global Top Human Coagulation Factor VIII Players by Revenue (2015-2020)
3.3 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Coagulation Factor VIII as of 2019)
3.4 Global Human Coagulation Factor VIII Average Price by Company (2015-2020)
3.5 Manufacturers Human Coagulation Factor VIII Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Human Coagulation Factor VIII Players (Opinion Leaders)
4 Global Human Coagulation Factor VIII Market Size by Type
4.1 Global Human Coagulation Factor VIII Historic Market Review by Type (2015-2020)
4.1.1 Global Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
4.1.2 Global Human Coagulation Factor VIII Revenue Market Share by Type (2015-2020)
4.1.3 Global Human Coagulation Factor VIII Price by Type (2014-2020)
4.2 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Human Coagulation Factor VIII Sales Forecast by Type (2021-2026)
4.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Type (2021-2026)
4.2.3 Global Human Coagulation Factor VIII Price Forecast by Type (2021-2026)
5 Global Human Coagulation Factor VIII Market Size by Application
5.1 Global Human Coagulation Factor VIII Historic Market Review by Application (2015-2020)
5.1.1 Global Human Coagulation Factor VIII Sales Market Share by Application (2015-2020)
5.1.2 Global Human Coagulation Factor VIII Revenue Market Share by Application (2015-2020)
5.1.3 Global Human Coagulation Factor VIII Price by Application (2015-2020)
5.2 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Human Coagulation Factor VIII Sales Forecast by Application (2021-2026)
5.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Coagulation Factor VIII Price Forecast by Application (2021-2026)
3 North America Human Coagulation Factor VIII Market Facts & Figures
3.2 North America Human Coagulation Factor VIII Sales Market Share by Company (2015-2020)
3.3 North America Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
3.4 North America Human Coagulation Factor VIII Sales Market Share by Application (2015-2020)
4 Europe Human Coagulation Factor VIII Market Facts & Figures
4.2 Europe Human Coagulation Factor VIII Sales Market Share by Company (2015-2020)
4.3 Europe Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
4.4 Europe Human Coagulation Factor VIII Sales Market Share by Application (2015-2020)
5 China Human Coagulation Factor VIII Market Facts & Figures
5.2 China Human Coagulation Factor VIII Sales Market Share by Company (2015-2020)
5.3 China Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
5.4 China Human Coagulation Factor VIII Sales Market Share by Application (2015-2020)
6 Japan Human Coagulation Factor VIII Market Facts & Figures
6.2 Japan Human Coagulation Factor VIII Sales Market Share by Company (2015-2020)
6.3 Japan Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
6.4 Japan Human Coagulation Factor VIII Sales Market Share by Application (2015-2020)
7 Southeast Asia Human Coagulation Factor VIII Market Facts & Figures
7.2 Southeast Asia Human Coagulation Factor VIII Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Human Coagulation Factor VIII Sales Market Share by Application (2015-2020)
8 India Human Coagulation Factor VIII Market Facts & Figures
8.2 India Human Coagulation Factor VIII Sales Market Share by Company (2015-2020)
8.3 India Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
8.4 India Human Coagulation Factor VIII Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Human Coagulation Factor VIII Business
12.1 Shire (Baxter)
12.1.1 Shire (Baxter) Human Coagulation Factor VIII Corporation Information
12.1.2 Shire (Baxter) Human Coagulation Factor VIII Business Overview and Total Revenue
12.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Shire (Baxter) Human Coagulation Factor VIII Products Offered
12.1.5 Shire (Baxter) Recent Development
12.2 Bayer
12.2.1 Bayer Human Coagulation Factor VIII Corporation Information
12.2.2 Bayer Human Coagulation Factor VIII Business Overview and Total Revenue
12.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer Human Coagulation Factor VIII Products Offered
12.2.5 Bayer Recent Development
12.3 CSL
12.3.1 CSL Human Coagulation Factor VIII Corporation Information
12.3.2 CSL Human Coagulation Factor VIII Business Overview and Total Revenue
12.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CSL Human Coagulation Factor VIII Products Offered
12.3.5 CSL Recent Development
12.4 Pfizer
12.4.1 Pfizer Human Coagulation Factor VIII Corporation Information
12.4.2 Pfizer Human Coagulation Factor VIII Business Overview and Total Revenue
12.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Human Coagulation Factor VIII Products Offered
12.4.5 Pfizer Recent Development
12.5 Grifols
12.5.1 Grifols Human Coagulation Factor VIII Corporation Information
12.5.2 Grifols Human Coagulation Factor VIII Business Overview and Total Revenue
12.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Grifols Human Coagulation Factor VIII Products Offered
12.5.5 Grifols Recent Development
12.6 Biogen
12.6.1 Biogen Human Coagulation Factor VIII Corporation Information
12.6.2 Biogen Human Coagulation Factor VIII Business Overview and Total Revenue
12.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Biogen Human Coagulation Factor VIII Products Offered
12.6.5 Biogen Recent Development
12.7 Octapharma
12.7.1 Octapharma Human Coagulation Factor VIII Corporation Information
12.7.2 Octapharma Human Coagulation Factor VIII Business Overview and Total Revenue
12.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Octapharma Human Coagulation Factor VIII Products Offered
12.7.5 Octapharma Recent Development
12.8 NovoNordisk
12.8.1 NovoNordisk Human Coagulation Factor VIII Corporation Information
12.8.2 NovoNordisk Human Coagulation Factor VIII Business Overview and Total Revenue
12.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2015-2020)
12.8.4 NovoNordisk Human Coagulation Factor VIII Products Offered
12.8.5 NovoNordisk Recent Development
12.9 Greencross
12.9.1 Greencross Human Coagulation Factor VIII Corporation Information
12.9.2 Greencross Human Coagulation Factor VIII Business Overview and Total Revenue
12.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Greencross Human Coagulation Factor VIII Products Offered
12.9.5 Greencross Recent Development
12.10 Kedrion
12.10.1 Kedrion Human Coagulation Factor VIII Corporation Information
12.10.2 Kedrion Human Coagulation Factor VIII Business Overview and Total Revenue
12.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Kedrion Human Coagulation Factor VIII Products Offered
12.10.5 Kedrion Recent Development
12.11 BPL
12.11.1 BPL Human Coagulation Factor VIII Corporation Information
12.11.2 BPL Human Coagulation Factor VIII Business Overview and Total Revenue
12.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2015-2020)
12.11.4 BPL Human Coagulation Factor VIII Products Offered
12.11.5 BPL Recent Development
12.12 Hualan Bio
12.12.1 Hualan Bio Human Coagulation Factor VIII Corporation Information
12.12.2 Hualan Bio Human Coagulation Factor VIII Business Overview and Total Revenue
12.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Hualan Bio Human Coagulation Factor VIII Products Offered
12.12.5 Hualan Bio Recent Development
12.13 RAAS
12.13.1 RAAS Human Coagulation Factor VIII Corporation Information
12.13.2 RAAS Human Coagulation Factor VIII Business Overview and Total Revenue
12.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2015-2020)
12.13.4 RAAS Human Coagulation Factor VIII Products Offered
12.13.5 RAAS Recent Development
13 Human Coagulation Factor VIII Manufacturing Cost Analysis
13.1 Human Coagulation Factor VIII Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Coagulation Factor VIII
13.4 Human Coagulation Factor VIII Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Coagulation Factor VIII Distributors List
14.3 Human Coagulation Factor VIII Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Human Coagulation Factor VIII Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Human Coagulation Factor VIII Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Human Coagulation Factor VIII Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Human Coagulation Factor VIII Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Human Coagulation Factor VIII Players to Combat Covid-19 Impact
Table 8. Global Market Human Coagulation Factor VIII Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Human Coagulation Factor VIII Sales (Kg) by Region (2015-2020)
Table 10. Global Human Coagulation Factor VIII Sales Market Share by Region (2015-2020)
Table 11. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Human Coagulation Factor VIII Revenue Share by Region (2015-2020)
Table 13. Global Human Coagulation Factor VIII Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Human Coagulation Factor VIII Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Human Coagulation Factor VIII Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Human Coagulation Factor VIII Revenue Share Forecast by Region (2021-2026)
Table 17. Global Human Coagulation Factor VIII (Kg) of Key Companies (2015-2020)
Table 18. Global Human Coagulation Factor VIII Sales Share by Company (2015-2020)
Table 19. Global Human Coagulation Factor VIII Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Human Coagulation Factor VIII Revenue Share by Company (2015-2020)
Table 21. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Coagulation Factor VIII as of 2019)
Table 22. Global Human Coagulation Factor VIII Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Human Coagulation Factor VIII Manufacturing Sites and Area Served
Table 24. Manufacturers Human Coagulation Factor VIII Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Human Coagulation Factor VIII Players
Table 27. Global Human Coagulation Factor VIII Sales (Kg) by Type (2015-2020)
Table 28. Global Human Coagulation Factor VIII Sales Share by Type (2015-2020)
Table 29. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Human Coagulation Factor VIII Price (Kg) by Type (2015-2020)
Table 31. Global Human Coagulation Factor VIII Sales Share by Type (2021-2026)
Table 32. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Human Coagulation Factor VIII Revenue Share by Type (2021-2026)
Table 34. Global Human Coagulation Factor VIII Price (Kg) by Type (2021-2026)
Table 35. Global Human Coagulation Factor VIII Sales (Kg) by Application (2015-2020)
Table 36. Global Human Coagulation Factor VIII Sales Share by Application (2015-2020)
Table 37. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Human Coagulation Factor VIII Price (Kg) by Application (2015-2020)
Table 39. Global Human Coagulation Factor VIII Sales (Kg) by Application (2021-2026)
Table 40. Global Human Coagulation Factor VIII Sales Share by Application (2021-2026)
Table 41. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Human Coagulation Factor VIII Revenue Share by Application (2021-2026)
Table 43. Global Human Coagulation Factor VIII Price (Kg) by Application (2021-2026)
Table 44. United States Human Coagulation Factor VIII Sales (Kg) by Company (2015-2020)
Table 45. United States Human Coagulation Factor VIII Sales Market Share by Company (2015-2020)
Table 46. United States Human Coagulation Factor VIII Sales (Kg) by Type (2015-2020)
Table 47. United States Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
Table 48. United States Human Coagulation Factor VIII Sales (Kg) by Application (2015-2020)
Table 49. United States Human Coagulation Factor VIII Sales Market Share by Application (2015-2020)
Table 50. Europe Human Coagulation Factor VIII Sales (Kg) by Company (2015-2020)
Table 51. Europe Human Coagulation Factor VIII Sales Market Share by Company (2015-2020)
Table 52. Europe Human Coagulation Factor VIII Sales (Kg) by Type (2015-2020)
Table 53. Europe Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
Table 54. Europe Human Coagulation Factor VIII Sales (Kg) by Application (2015-2020)
Table 55. Europe Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
Table 56. China Human Coagulation Factor VIII Sales (Kg) by Company (2015-2020)
Table 57. China Human Coagulation Factor VIII Sales Market Share by Company (2015-2020)
Table 58. China Human Coagulation Factor VIII Sales (Kg) by Type (2015-2020)
Table 59. China Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
Table 60. China Human Coagulation Factor VIII Sales (Kg) by Application (2015-2020)
Table 61. China Human Coagulation Factor VIII Sales Market Share by Application (2015-2020)
Table 62. Japan Human Coagulation Factor VIII Sales (Kg) by Company (2015-2020)
Table 63. Japan Human Coagulation Factor VIII Sales Market Share by Company (2015-2020)
Table 64. Japan Human Coagulation Factor VIII Sales (Kg) by Type (2015-2020)
Table 65. Japan Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
Table 66. Japan Human Coagulation Factor VIII Sales (Kg) by Application (2015-2020)
Table 67. Japan Human Coagulation Factor VIII Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Human Coagulation Factor VIII Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Human Coagulation Factor VIII Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Human Coagulation Factor VIII Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Application (2015-2020)
Table 74. India Human Coagulation Factor VIII Sales (Kg) by Company (2015-2020)
Table 75. India Human Coagulation Factor VIII Sales Market Share by Company (2015-2020)
Table 76. India Human Coagulation Factor VIII Sales (Kg) by Type (2015-2020)
Table 77. India Human Coagulation Factor VIII Sales Market Share by Type (2015-2020)
Table 78. India Human Coagulation Factor VIII Sales (Kg) by Application (2015-2020)
Table 79. India Human Coagulation Factor VIII Sales Market Share by Application (2015-2020)
Table 80. Shire (Baxter) Corporation Information
Table 81. Shire (Baxter) Description and Business Overview
Table 82. Shire (Baxter) Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Shire (Baxter) Human Coagulation Factor VIII Product
Table 84. Shire (Baxter) Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Bayer Human Coagulation Factor VIII Product
Table 89. Bayer Recent Development
Table 90. CSL Corporation Information
Table 91. CSL Description and Business Overview
Table 92. CSL Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. CSL Human Coagulation Factor VIII Product
Table 94. CSL Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Pfizer Human Coagulation Factor VIII Product
Table 99. Pfizer Recent Development
Table 100. Grifols Corporation Information
Table 101. Grifols Description and Business Overview
Table 102. Grifols Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Grifols Human Coagulation Factor VIII Product
Table 104. Grifols Recent Development
Table 105. Biogen Corporation Information
Table 106. Biogen Description and Business Overview
Table 107. Biogen Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Biogen Human Coagulation Factor VIII Product
Table 109. Biogen Recent Development
Table 110. Octapharma Corporation Information
Table 111. Octapharma Description and Business Overview
Table 112. Octapharma Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Octapharma Human Coagulation Factor VIII Product
Table 114. Octapharma Recent Development
Table 115. NovoNordisk Corporation Information
Table 116. NovoNordisk Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. NovoNordisk Description and Business Overview
Table 118. NovoNordisk Human Coagulation Factor VIII Product
Table 119. NovoNordisk Recent Development
Table 120. Greencross Corporation Information
Table 121. Greencross Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Greencross Description and Business Overview
Table 123. Greencross Human Coagulation Factor VIII Product
Table 124. Greencross Recent Development
Table 125. Kedrion Corporation Information
Table 126. Kedrion Description and Business Overview
Table 127. Kedrion Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Kedrion Human Coagulation Factor VIII Product
Table 129. Kedrion Recent Development
Table 130. BPL Corporation Information
Table 131. BPL Description and Business Overview
Table 132. BPL Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. BPL Human Coagulation Factor VIII Product
Table 134. BPL Recent Development
Table 135. Hualan Bio Corporation Information
Table 136. Hualan Bio Description and Business Overview
Table 137. Hualan Bio Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 138. Hualan Bio Human Coagulation Factor VIII Product
Table 139. Hualan Bio Recent Development
Table . RAAS Corporation Information
Table . RAAS Description and Business Overview
Table . RAAS Human Coagulation Factor VIII Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . RAAS Human Coagulation Factor VIII Product
Table . RAAS Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Human Coagulation Factor VIII Distributors List
Table 148. Human Coagulation Factor VIII Customers List
Table 149. Market Key Trends
Table 150. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 151. Key Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Coagulation Factor VIII Market Share by Application in 2020 & 2026
Figure 6. Hemophilia A Examples
Figure 7. Spontanous / Trauma Examples
Figure 8. Surgical Examples
Figure 9. Other Examples
Figure 10. Global Human Coagulation Factor VIII Sales (Kg) Growth Rate (2015-2026)
Figure 11. Global Human Coagulation Factor VIII Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Human Coagulation Factor VIII Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 13. Global Human Coagulation Factor VIII Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Human Coagulation Factor VIII Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Human Coagulation Factor VIII Sales (Kg) Growth Rate (2015-2026)
Figure 17. Europe Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Human Coagulation Factor VIII Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Human Coagulation Factor VIII Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Human Coagulation Factor VIII Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Human Coagulation Factor VIII Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Human Coagulation Factor VIII Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Human Coagulation Factor VIII Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Human Coagulation Factor VIII Players Market Share by Revenue in Human Coagulation Factor VIII 2015 & 2019
Figure 28. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Human Coagulation Factor VIII Revenue Share by Type (2015-2020)
Figure 30. Global Human Coagulation Factor VIII Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Human Coagulation Factor VIII Revenue Share by Application (2015-2020)
Figure 32. Global Human Coagulation Factor VIII Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Human Coagulation Factor VIII Sales Market Share by Type in 2019
Figure 34. United States Human Coagulation Factor VIII Sales Market Share by Type in 2019
Figure 35. Europe Human Coagulation Factor VIII Sales Market Share by Company in 2019
Figure 36. Europe Human Coagulation Factor VIII Sales Market Share by Type in 2019
Figure 37. Europe Human Coagulation Factor VIII Sales Market Share by Application in 2019
Figure 38. China Human Coagulation Factor VIII Sales Market Share by Company in 2019
Figure 39. China Human Coagulation Factor VIII Sales Market Share by Type in 2019
Figure 40. China Human Coagulation Factor VIII Sales Market Share by Application in 2019
Figure 41. Japan Human Coagulation Factor VIII Sales Market Share by Company in 2019
Figure 42. Japan Human Coagulation Factor VIII Sales Market Share by Type in 2019
Figure 43. Japan Human Coagulation Factor VIII Sales Market Share by Application in 2019
Figure 44. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Company in 2019
Figure 45. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Type in 2019
Figure 46. Southeast Asia Human Coagulation Factor VIII Sales Market Share by Application in 2019
Figure 47. India Human Coagulation Factor VIII Sales Market Share by Company in 2019
Figure 48. India Human Coagulation Factor VIII Sales Market Share by Type in 2019
Figure 49. India Human Coagulation Factor VIII Sales Market Share by Application in 2019
Figure 50. Shire (Baxter) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. NovoNordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Greencross Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Kedrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. BPL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. RAAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Key Raw Materials Price Trend
Figure 64. Manufacturing Cost Structure of Human Coagulation Factor VIII
Figure 65. Manufacturing Process Analysis of Human Coagulation Factor VIII
Figure 66. Human Coagulation Factor VIII Industrial Chain Analysis
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. Porter's Five Forces Analysis
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
ヒト凝固因子Ⅷの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Coagulation Factor Ⅷ market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Coagulation …- 凝固因子IXの世界市場レポート2020 Market Analysis and Insights: Global Coagulation Factor IX Market The global Coagulation Factor IX market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Coagulation Factor IX Scope and Market Size The global Co…
- 凝固因子濃縮物の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Coagulation Factor Concentrate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Coagulation Fa…
- インスリン様成長因子の世界市場レポート2020 Market Analysis and Insights: Global Insulin Like Growth Factor Market The global Insulin Like Growth Factor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Insulin Like Growth Factor Scope and Market Siz…
- 結合組織成長因子の世界市場レポート2020 Market Analysis and Insights: Global Connective Tissue Growth Factor Market The global Connective Tissue Growth Factor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Connective Tissue Growth Factor Scope…